Evidence map›Paper›PMID 30839899›Full record

ArticleInfectious Disease Modelling2018

A primer on the use of probability generating functions in infectious disease modeling.

Joel C Miller

Abstract read
In one paragraph

Article in Infectious Disease Modelling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Review
  9. Article
  10. BeyondJournal of the Royal Society, Interface · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joel C MillerInstitute for Disease Modeling, Bellevue, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We explore the application of probability generating functions (PGFs) to invasive processes, focusing on infectious disease introduced into large populations. Our goal is to acquaint the reader with applications of PGFs, moreso than to derive new results. PGFs help predict a number of properties about early outbreak behavior while the population is still effectively infinite, including the probability of an epidemic, the size distribution after some number of generations, and the cumulative size distribution of non-epidemic outbreaks. We show how PGFs can be used in both discrete-time and continuous-time settings, and discuss how to use these results to infer disease parameters from observed outbreaks. In the large population limit for susceptible-infected-recovered (SIR) epidemics PGFs lead to survival-function based models that are equivalent to the usual mass-action SIR models but with fewer ODEs. We use these to explore properties such as the final size of epidemics or even the dynamics once stochastic effects are negligible. We target this primer at biologists and public health researchers with mathematical modeling experience who want to learn how to apply PGFs to invasive diseases, but it could also be used in an applications-based mathematics course on PGFs. We include many exercises to help demonstrate concepts and to give practice applying the results. We summarize our main results in a few tables. Additionally we provide a small python package which performs many of the relevant calculations.

Identifiers

PMID30839899
PMCPMC6326237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.